European Commission authorizes Moderna's coronavirus vaccine

  • 2021-01-06

BRUSSELS - The European Commission on Wednesday authorized the vaccine against the coronavirus developed by US pharmaceutical company Moderna for use in the European Union (EU), the Commission's President Ursula von der Leyen informed. 

"We are providing safe & effective #COVID19 vaccines for Europeans," Leyen tweeted.

The European Commission has ordered 160 million doses of the Moderna vaccine.

Hours earlier, the European Medicines Agency (EMA) approved the Moderna vaccine for use in the EU. 

The vaccine developed by US pharmaceutical company Moderna has shown an efficacy rate of 94.1 percent.

The vaccine is the second to be authorised by the European Medicines Agency (EMA) for the 27-nation bloc after Pfizer-BioNTech's got the green light in late December.